Clinical Outcomes of Patients With COVID19
Withdrawn
- Conditions
- Coronavirus Disease 2019
- Interventions
- Other: retrospective analysis
- Registration Number
- NCT04280913
- Lead Sponsor
- Guangzhou Institute of Respiratory Disease
- Brief Summary
As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Hospitalized patients with COVID19
Exclusion Criteria
- Suspected patients with COVID19, not confirmed by the laboratory
- Patients who are refused to receive medical treatments
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID-19 patients retrospective analysis Hospitalized patients with COVID-19
- Primary Outcome Measures
Name Time Method Time to negative conversion of severe acute respiratory syndrome coronavirus 2 1 month The primary outcome is the time to negative conversion of coronavirus
- Secondary Outcome Measures
Name Time Method Length of stay in hospital 1 month The time of hospitalization.
Survival 1 month The rate of survival within hospitalization of these patients will be tracked.
Intubation 1 month The rate of intubation within hospitalization of these patients will be tracked.
Trial Locations
- Locations (1)
HuiZhou Municipal Central Hospital
🇨🇳Huizhou, Guangdong, China